pazopanib

Generic: pazopanib hydrochloride

Labeler: torrent pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pazopanib
Generic Name pazopanib hydrochloride
Labeler torrent pharmaceuticals limited
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

pazopanib hydrochloride 400 mg/1

Manufacturer
Torrent Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 13668-735
Product ID 13668-735_f57f2d5c-15b9-443a-a6d3-d09287296ab2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA219922
Listing Expiration 2026-12-31
Marketing Start 2025-09-04

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 13668735
Hyphenated Format 13668-735

Supplemental Identifiers

RxCUI
867508
UPC
0313668735307
UNII
33Y9ANM545

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pazopanib (source: ndc)
Generic Name pazopanib hydrochloride (source: ndc)
Application Number ANDA219922 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (13668-735-30)
  • 60 TABLET, FILM COATED in 1 BOTTLE (13668-735-60)
  • 90 TABLET, FILM COATED in 1 BOTTLE (13668-735-90)
source: ndc

Packages (3)

Ingredients (1)

pazopanib hydrochloride (400 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f57f2d5c-15b9-443a-a6d3-d09287296ab2", "openfda": {"upc": ["0313668735307"], "unii": ["33Y9ANM545"], "rxcui": ["867508"], "spl_set_id": ["7235fad0-eb5b-4fdf-a362-c8c65c9bfe1d"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (13668-735-30)", "package_ndc": "13668-735-30", "marketing_start_date": "20250904"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (13668-735-60)", "package_ndc": "13668-735-60", "marketing_start_date": "20250904"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (13668-735-90)", "package_ndc": "13668-735-90", "marketing_start_date": "20250904"}], "brand_name": "pazopanib", "product_id": "13668-735_f57f2d5c-15b9-443a-a6d3-d09287296ab2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "13668-735", "generic_name": "pazopanib hydrochloride", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pazopanib", "active_ingredients": [{"name": "PAZOPANIB HYDROCHLORIDE", "strength": "400 mg/1"}], "application_number": "ANDA219922", "marketing_category": "ANDA", "marketing_start_date": "20250904", "listing_expiration_date": "20261231"}